Timescale dependent homogeneous assembly of lipid-polymer hybrid nanoparticles in laminar mixing for enhanced lung cancer treatment

被引:3
作者
Li, ShiXin [1 ]
Yang, Bing [1 ,2 ]
Ye, Liang [1 ]
Hu, ShuQi [1 ]
Li, BenHong [1 ]
Yang, Yanjun [1 ]
Jia, XiaoBin [1 ,2 ]
Feng, Liang [1 ,2 ]
Xiong, ZhiWei [1 ,2 ]
机构
[1] China Pharmaceut Univ, Affiliated Jiangning Hosp Chinese Med, Sch Tradit Chinese Pharm, Nanjing, Peoples R China
[2] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing 211198, Jiangsu, Peoples R China
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
Quality control; Laminar mixing; Growth timescale; Coating timescale Homogeneous; Lung cancer; MICROFLUIDIC SYNTHESIS; CELLULAR UPTAKE; IN-VITRO; DRUG; NANOCOMPOSITES; PLATFORM; RELEASE; LAYER;
D O I
10.1016/j.cej.2024.155625
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The homogeneity of core-shell structure lipid-polymer hybrid nanoparticles (HNPs) is crucial for efficient intracellular cargo delivery. While microfluidic techniques have been recognized for their capabilities in precisely controlling the size and drug encapsulation efficiency, there is little research exploring the impact of mass transfer behavior within microchannels on the homogeneous assembly process of HNPs. Here, we manipulated the laminar flow state within TrM device to achieve controlled assembly of HNPs and explored a timescale dependent assembly technique to ensure the homogeneity of folate modified HNPs (FHNPs). Our founding indicate that this method enabled the control over the growth kinetics of PLGA cores within a timescale (tau (grow) ) of 1-15 ms. The homogeneous ligand assembly on the surface of FHNPs can only be achieved when tau (grow )exceeds the timescale of functional lipid coating (tau (coating )). Compared to conventional bulk mixing methods, this strategy significantly reduces the risk of heterogeneous assembly in FHNPs fabrication and ensures consistent reproducibility across batches. The homogeneous FHNPs (HFHNPs) fabricated through this method exhibit precise control over particle size (ranging from 75 nm to 150 nm), low polydispersity index, and consistent core-shell structure. Furthermore, this strategy enhances the density of available folate ligands on the surface of FHNPs. In subsequent in vitro and in vivo anti-tumor assays, the icariside II (IS) loaded HFHNPs (IS@HFHNPs) exhibited enhanced cellular uptake and tumor accumulation behavior. the timescale dependent homogeneous assembly method for HNPs developed in this research presents a promising avenue for maintaining quality in the synthesis of self-assembly composite nanomecidine.
引用
收藏
页数:16
相关论文
共 52 条
[1]   Integrated Microfluidic Synthesis of Aptamer Functionalized Biozeolitic Imidazolate Framework (BioZIF-8) Targeting Lymph Node and Tumor [J].
Balachandran, Yekkuni L. ;
Li, Xuanyu ;
Jiang, Xingyu .
NANO LETTERS, 2021, 21 (03) :1335-1344
[2]   Active and passive micromixers: A comprehensive review [J].
Bayareh, Morteza ;
Ashani, Mohsen Nazemi ;
Usefian, Azam .
CHEMICAL ENGINEERING AND PROCESSING-PROCESS INTENSIFICATION, 2020, 147
[3]   Peptide Self-assembly: From Ordered to Disordered Published as part of Accounts of Chemical Research virtual special issue "Peptide Materials" [J].
Chang, Rui ;
Yuan, Chengqian ;
Zhou, Peng ;
Xing, Ruirui ;
Yan, Xuehai .
ACCOUNTS OF CHEMICAL RESEARCH, 2024, 57 (03) :289-301
[4]   Quantification of Available Ligand Density on the Surface of Targeted Liposomal Nanomedicines at the Single-Particle Level [J].
Chen, Chaoxiang ;
Zhou, Yingxing ;
Chen, Chen ;
Zhu, Shaobin ;
Yan, Xiaomei .
ACS NANO, 2022, 16 (04) :6886-6897
[5]   Microfluidics-enabled Serial Assembly of Lipid-siRNA-sorafenib Nanoparticles for Synergetic Hepatocellular Carcinoma Therapy [J].
Chen, Yao ;
Zhao, Dong ;
Xiao, Feng ;
Li, Xuanyu ;
Li, Jia'an ;
Su, Zhenwei ;
Jiang, Xingyu .
ADVANCED MATERIALS, 2023, 35 (13)
[6]   Transbilayer (flip-flop) lipid motion and lipid scrambling in membranes [J].
Contreras, F. -Xabier ;
Sanchez-Magraner, Lissete ;
Alonso, Alicia ;
Goni, Felix M. .
FEBS LETTERS, 2010, 584 (09) :1779-1786
[7]   Lipid polymer hybrid nanoparticles: a custom-tailored next-generation approach for cancer therapeutics [J].
Gajbhiye, Kavita R. ;
Salve, Rajesh ;
Narwade, Mahavir ;
Sheikh, Afsana ;
Kesharwani, Prashant ;
Gajbhiye, Virendra .
MOLECULAR CANCER, 2023, 22 (01)
[8]  
Gusmao L.A., 2022, Drug Deliv., P101, DOI [10.1016/b978-0-323-85754-3.00003-4, DOI 10.1016/B978-0-323-85754-3.00003-4]
[9]   Electrospun lipid-coated medicated nanocomposites for an improved drug sustained-release profile [J].
Hai, Tao ;
Wan, Xi ;
Yu, Deng-Guang ;
Wang, Ke ;
Yang, Yaoyao ;
Liu, Zhe-Peng .
MATERIALS & DESIGN, 2019, 162 :70-79
[10]   Carbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivo [J].
Hassan, Hatem A. F. M. ;
Smyth, Lesley ;
Rubio, Noelia ;
Ratnasothy, Kulachelvy ;
Wang, Julie T. -W. ;
Bansal, Sukhvinder S. ;
Summers, Huw D. ;
Diebold, Sandra S. ;
Lombardi, Giovanna ;
Al-Jamal, Khuloud T. .
JOURNAL OF CONTROLLED RELEASE, 2016, 225 :205-216